Skip to main content

Table 2 Data of patient with malignant odontogenic tumours (MOTs)

From: Clinico-pathological study of malignant odontogenic tumours from a national referral centre

Case

Age range (years)

Ethnicity

Site

Diagnosis

Treatment

1

50–59

Malay

Mandible

Ameloblastic carcinoma

Surgery

2

20–29

Malay

Mandible

Ameloblastic carcinoma

Surgery

3

40–49

Malay

Mandible

Ameloblastic carcinoma

Surgery

4

60–69

Malay

Mandible

Clear cell odontogenic carcinoma

Surgery

5

50–59

Dusun

Maxilla

Primary intraosseous carcinoma NOS

Surgery

6

40–49

Chinese

Mandible

Clear cell odontogenic carcinoma

Surgery

7

50–59

Malay

Mandible

Primary intraosseous carcinoma NOS

Surgery

8

50–59

Indian

Mandible

Primary intraosseous carcinoma NOS

Surgery

9

20–29

Iban

Mandible

Ameloblastic carcinoma

Surgery

10

40–49

Malay

Mandible

Ameloblastic carcinoma

Palliative

11

70–79

Indian

Maxilla

Ameloblastic carcinoma

Palliative

12

40–49

Bajau

Maxilla

Primary intraosseous carcinoma NOS

Surgery

13

40–49

Malay

Maxilla

Primary intraosseous carcinoma NOS

Surgery

14

60–69

Malay

Mandible

Primary intraosseous carcinoma NOS

Surgery

15

50–59

Malay

Mandible

Primary intraosseous carcinoma NOS

Surgery

16

50–59

Malay

Mandible

Ameloblastic carcinoma

Surgery and concurrent chemoradiotherapy

17

70–79

Malay

Maxilla

Clear cell odontogenic carcinoma

Declined

18

60–69

Malay

Mandible

Ameloblastic carcinoma

Declined

19

40–49

Malay

Mandible

Ameloblastic carcinoma

Surgery and radiotherapy

20

10–19

Malay

Mandible

Ameloblastic carcinoma

Surgery

21

40–49

Malay

Mandible

Primary intraosseous carcinoma NOS

Surgery

22

70–79

Chinese

Mandible

Ghost cell odontogenic carcinoma

Surgery

23

50–59

Malay

Mandible

Ameloblastic carcinoma

Surgery

24

20–29

Chinese

Mandible

Primary intraosseous carcinoma NOS

Surgery and radiotherapy

  1. NOS, not otherwise specified